Financhill
Back

Sonoma Pharmaceuticals, Inc. Vs. Bowman Consulting Group Ltd. Industry Stock Comparison

Sell
21

SNOA
Sonoma Pharmaceuticals, Inc.

Last Price:
$2.32
Seasonality Move:
6.9%
Sell
44

BWMN
Bowman Consulting Group Ltd.

Last Price:
$29.63
Seasonality Move:
1.39%
Sell
21
Sonoma Pharmaceuticals, Inc. (SNOA) is a Sell

Is Sonoma Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Sonoma Pharmaceuticals, Inc. [SNOA] share price is $2.37. The Score for SNOA is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
  • SNOA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Bowman Consulting Group Ltd. (BWMN) is a Sell

Is Bowman Consulting Group Ltd. a Buy, Sell or Hold?

  • The current Bowman Consulting Group Ltd. [BWMN] share price is $29.65. The Score for BWMN is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • BWMN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SNOA Stock Price Chart

What is Sonoma Pharmaceuticals, Inc.'s stock price today?

  • The Sonoma Pharmaceuticals, Inc. share price today is $2.37
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SNOA is experiencing buying pressure, which is a positive indicator for future bullish movement.

BWMN Stock Price Chart

What is Bowman Consulting Group Ltd.'s stock price today?

  • The Bowman Consulting Group Ltd. share price today is $29.65
    The current trend is relatively stagnant and BWMN is experiencing buying pressure, which is a positive indicator for future bullish movement.

SNOA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.59 Buy
Relative Strength Index (14 RSI): 45.79 Sell
Chaikin Money Flow: 8005 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.23 - 2.67) Sell
Bollinger Bands (100): (2.65 - 3.61) Sell

BWMN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 49.61 Sell
Chaikin Money Flow: 51978 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (27.4 - 31.18) Buy
Bollinger Bands (100): (30.57 - 35.89) Sell

SNOA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.23 Buy
20-day SMA: 2.37 Buy
50-day SMA: 2.75 Sell
200-day SMA: 3.49 Sell
8-day EMA: 2.17 Buy
20-day EMA: 1.6 Buy
50-day EMA: 0.88 Buy
200-day EMA: 0.26 Buy

BWMN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.98 Buy
20-day SMA: 28.55 Buy
50-day SMA: 31.74 Sell
200-day SMA: 35.62 Sell
8-day EMA: 28.94 Buy
20-day EMA: 29.27 Buy
50-day EMA: 31.11 Sell
200-day EMA: 33.16 Sell

Sonoma Pharmaceuticals, Inc. Earnings Growth & SNOA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.19 per share, and an increase next year of $1.05 per share.

Bowman Consulting Group Ltd. Earnings Growth & BWMN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.11 per share, an increase this year of $0.09 per share, and an increase next year of $0.56 per share.

Sonoma Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Bowman Consulting Group Ltd. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):